Clinical Trials Directory

Trials / Completed

CompletedNCT03949712

Pediatric Transcranial Static Magnetic Field Stimulation to Improve Motor Learning

Effects of Transcranial Static Magnetic Field Stimulation (tSMS) on Motor Learning and Cortical Neurophysiology in the Developing Brain

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
24 (actual)
Sponsor
University of Calgary · Academic / Other
Sex
All
Age
8 Years – 18 Years
Healthy volunteers
Accepted

Summary

Non-invasive brain stimulation (NIBS) is a safe, painless way to improve brain function. It is used for many conditions, including to help children with disabilities. However, it can be challenging to apply NIBS in very young children and infants. A new, simple form of NIBS called transcranial static magnetic field stimulation (tSMS) is a promising tool for early brain stimulation. tSMS in adults has been shown to be safe, tolerable and have the desired effects on brain activity when applied to the motor cortex of the brain. However, how tSMS affects on motor function is not understood. This research will use tSMS to target the motor cortex which is responsible for voluntary movement. The study will determine if tSMS can improve motor learning in healthy children. It is hypothesized that application of tSMS on the right motor cortex will decrease excitability of the motor cortex and will lead to improved motor learning in the right hand. tSMS has the potential to become a safe, inexpensive, home-based way to enhance personalized rehabilitation for disabled children.

Conditions

Interventions

TypeNameDescription
DEVICETranscranial Static Magnetic Field Stimulation (tSMS)tSMS consists of a small compact cylindrical neodynium magnet (S-45-30-N, Supermagnete) with an estimated strength of up to 0.5 Tesla and a size of 30 mm x 45 mm.
DEVICESham Transcranial Static Magnetic Field Stimulation (tSMS)Sham tSMS consists of a small compact metal cylinder, identical in appearance to the real tSMS device.

Timeline

Start date
2018-03-30
Primary completion
2019-06-01
Completion
2019-06-01
First posted
2019-05-14
Last updated
2019-08-05

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03949712. Inclusion in this directory is not an endorsement.